Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
The node of Ranvier in CNS pathology.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
[Effect of LINGO-1 gene silencing on movement function of EAE mice].
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
"Media, politics and science policy: MS and evidence from the CCSVI Trenches".
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.
Gait termination in individuals with multiple sclerosis.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
Monoclonal Antibodies for Multiple Sclerosis Treatment.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Employment and multiple sclerosis: Policy, programming, and research recommendations.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'

Pages